Skip to main content
OpenTrials

Clinical trial condition

Psoriasis

Explore clinical trials studying Psoriasis. Study availability and eligibility vary by location and protocol.

1,174 public trials 112 recruiting studies
Refine in advanced search Browse all conditions

Psoriasis trial results

Completed

CP-690-550 Ointment For Chronic Plaque Psoriasis

NCT01246583

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Horizon Research Group, Inc. Mobile, Alabama, United States
  • Dermatology Research Associates Los Angeles, California, United States
  • Expresscare Medical Los Angeles, California, United States
  • Park Avenue Dermatology, PA Orange Park, Florida, United States
View Trial Details
Completed

Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year

NCT01365455

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +14 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Los Angeles, California, United States
View all 88 locations
View Trial Details
Completed

Efficacy and Safety of Subcutaneous Secukinumab in Adults With Moderate to Severe Scalp Psoriasis

NCT02267135

Conditions
Chronic Scalp Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Novartis Investigative Site Sacramento, California, United States
  • Novartis Investigative Site Aurora, Colorado, United States
  • Novartis Investigative Site Trumbull, Connecticut, United States
  • Novartis Investigative Site Rockville, Maryland, United States
View all 17 locations
View Trial Details
Completed

Study to Evaluate the Effect of Secukinumab Compared to Placebo on Aortic Vascular Inflammation in Subjects With Moderate to Severe Plaque Psoriasis

NCT02690701

Conditions
Chronic Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis Investigative Site Santa Ana, California, United States
  • Novartis Investigative Site Rockville, Maryland, United States
  • Novartis Investigative Site St Louis, Missouri, United States
View Trial Details
Completed

Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis

NCT01358578

Conditions
Chronic Plaque Psoriasis, Dermatitis, Psoriasis, +3 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site San Diego, California, United States
  • Novartis Investigative Site San Diego, California, United States
View all 152 locations
View Trial Details
Completed

Topical CP-690,550 For Chronic Plaque Psoriasis

NCT00678561

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • University of California Irvine Irvine, California, United States
  • Therapeutics Clinical Research San Diego, California, United States
  • RUSH University Medical Center Chicago, Illinois, United States
  • Tufts Medical Center Boston, Massachusetts, United States
View all 20 locations
View Trial Details
Completed

A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis

NCT00885196

Conditions
Dermatitis, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Burke Pharmaceutical Research Hot Springs, Arizona, United States
  • Belleair Research Center, LLC Pinellas Park, Florida, United States
  • Kansas City Dermatology, PA Overland Park, Kansas, United States
  • Dermatology Specialists Louisville, Kentucky, United States
View all 40 locations
View Trial Details
Completed

Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability of CJM112 in Psoriasis

NCT01828086

Conditions
Chronic Plaque-type Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Novartis Investigative Site Anniston, Alabama, United States
  • Novartis Investigative Site Anaheim, California, United States
  • Novartis Investigative Site Encino, California, United States
  • Novartis Investigative Site North Hollywood, California, United States
View all 18 locations
View Trial Details

Related conditions